The Company leases certain manufacturing plants, warehouses, offices, and machinery and equipment. At the lease commencement date, the Company classifies a lease as a finance lease if it has the right to obtain substantially all of the economic benefits from the right-of-use assets, otherwise the lease is classified as an operating lease. The Company's leases have remaining noncancelable lease terms of less than one year to approximately 15 years, and typically require fixed monthly rental payments that may be adjusted annually to give effect to inflation. Real estate leases typically provide the Company options to extend the leases for up to 15 years. Finance leases for machinery and equipment typically include nominal purchase options at the end of the lease term that are reasonably certain of being exercised at the lease commencement date. Machinery and equipment operating leases typically include purchase options for the fair market value of the underlying asset at the end of the lease term, which are uncertain of being exercised at the lease commencement date.

	December 30, 2023		December 31, 2022
	$		$
Balance Sheet Classification
Operating leases:
Operating lease right-of-use assets	105,919		78,761

Current portion of operating lease liabilities	15,808		12,499
Operating lease liabilities	100,102		74,329
Total operating lease liabilities	115,910		86,828

Finance leases:
Property, plant and equipment, gross	81,423		153,976
Accumulated depreciation	(18,319	)	(18,168	)
Property, plant and equipment, net	63,104		135,808

Current portion of long-term debt	15,346		33,283
Long-term debt	37,284		90,796
Total finance lease liabilities	52,630		124,079

	December 30, 2023		December 31, 2022		January 1, 2022
	$		$		$
Cash Flow Information
Cash paid (received) for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	13,852		12,320		11,098
Operating cash flows from finance leases	9,310		5,136		2,727
Financing cash flows from finance leases
Cash paid under finance leases⁽¹⁾	89,087		19,903		8,439
Cash received under finance leases⁽²⁾	(6,568	)	(58,764	)	(13,626	)

Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	35,601		49,662		27,909
Finance leases	9,651		31,466		29,906

Right-of-use assets and liabilities reduced through lease terminations or modifications:
Operating leases	(914	)	(4,060	)	(2,261	)

(1) Represents repayments under finance leases recorded as a reduction of the lease liability and reported in repayment of long-term debt on the consolidated statements of cash flows. For the year ended December 30, 2023, lease repayments include $56.0 million paid by the Company to terminate certain finance lease obligations and purchase the related underlying right-of-use assets in connection with the refinancing of the Company's credit facilities on December 8, 2023 (see note 10). The difference of $4.4 million between the purchase price and the carrying amount of the finance lease obligations is reported in additions to property, plant and equipment on the consolidated statement of cash flows for the year ended December 30, 2023.

(2) Represents cash advances received by the Company under finance leases for the construction of right-of-use assets controlled by the Company, which related to the buildouts of the Company's new plant-based beverage facility in Midlothian, Texas, and the Company's executive office and innovation center located in Eden Prairie, Minnesota, as well as cash proceeds under sale and leaseback transactions accounted for as financings. Cash received under finance leases is reported in borrowings of long-term debt on the consolidated statements of cash flows.

	December 30, 2023	December 31, 2022	January 1, 2022
Other Information
Weighted-average remaining lease term (years):
Operating leases	12.0	12.9	7.6
Finance leases	3.2	3.5	4.3

Weighted-average discount rate:
Operating leases	8.7%	8.8%	5.1%
Finance leases	7.9%	8.2%	6.6%

As at December 30, 2023, the Company had entered into a finance lease agreement to provide for approximately $25 million of financing related to an expansion of the Company's ingredient extraction operations at its Modesto, California, facility, which is expected to become operational during the first half of 2024. As this finance lease had not commenced as at December 30, 2023, no amount of underlying right-of-use assets, or lease liabilities, were recognized on the consolidated balance sheet as of that date.